SCHEMBL5052005

SCHEMBL5052005

CCC(C)[C@H](N[C]=O)C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ENPEP Q07075 4/20 0.39
ALDH1A1 P00352 1/20 0.39
L3MBTL1 Q9Y468 2/20 0.34
HTT P42858 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33
KDM4E B2RXH2 1/20 0.32
CA2 P00918 3/20 0.32
CA1 P00915 2/20 0.32
MME P08473 2/20 0.31
ACE P12821 2/20 0.31
CPA1 P15085 2/20 0.31
ACE2 Q9BYF1 2/20 0.31
CNR2 P34972 1/20 0.30
FPR2 P25090 1/20 0.30
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30
ATM Q13315 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8016718 1.00 ENPEP (0.39) ENPEPALDH1A1L3MBTL1HTTCTSS
SCHEMBL5050524 0.82 ALDH1A1 (0.34) ENPEPALDH1A1L3MBTL1CA2CA1
SCHEMBL8024023 0.82 ALDH1A1 (0.53) ENPEPALDH1A1L3MBTL1CTSSCTSK
SCHEMBL4119105 0.79 HPGDS (0.31)
SCHEMBL8017536 0.78 POLB (0.41) ALDH1A1HTTKDM4E
SCHEMBL7405326 0.77 ALDH1A1 (0.37) ALDH1A1L3MBTL1CTSSCTSK
SCHEMBL7556071 0.77 ALDH1A1 (0.49) ENPEPALDH1A1L3MBTL1CTSSCTSK
SCHEMBL23573085 0.77
SCHEMBL14687077 0.77 ALDH1A1 (0.47) ENPEPALDH1A1L3MBTL1HTTKDM4E
SCHEMBL14687076 0.77 ALDH1A1 (0.47) ENPEPALDH1A1L3MBTL1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7375127-B2 Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) AE ZENTARIS GMBH (DE) 2008-05-20 US disclosed
US-20060014818-A1 Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) MUSC FOUNDATION FOR RESEARCH DEVELOPMENT 2006-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060014818-A1 Novel tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) GPR88, GPR34, GPR35 ENPEP 1922/4885ALDH1A1 3119/4885L3MBTL1 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.